One Shot, Nearly a Year of Lower Lp(a): My Honest Read of the Kylo-11 Lancet Study
A physician's close read of the first-in-human Kylo-11 trial in The Lancet: one siRNA shot lowered Lp(a) by about 53 to 97% at 48 weeks. What excites me, where I pump the brakes, and why it is worth asking for the Lp(a) lab.
More Than Half of Healthy Adults Had Silent Plaque: My Read of the REACT Study
REACT imaged the carotid, femoral and coronary arteries of adults aged 18 to 70 without known cardiovascular disease and found silent atherosclerosis in 57.1%. My read of what the study shows, what it does not, and how I plan to use it.